Abbott Laboratories
97,50 $Variación respecto al cierre anterior: +0,84 %Variación absoluta: +0,81 $
En resumen
- Crecimiento de los ingresos
- +5,67 %
- 2025 frente a 2024
- Crecimiento del beneficio neto
- −51,32 %
- 2025 frente a 2024
- Margen neto
- 14,7 %
- 2024: 31,9 %
Datos financieros
Importes en millones de USD; valores por acción en USD; acciones en millones.
| Partida | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Flujo de caja operativo | 9.566 | 8.558 | 7.261 | 9.581 | 10.533 | 7.901 | 6.136 | 6.300 | 5.570 | 3.203 |
| Amortizaciones | 3.116 | 3.218 | 3.243 | 3.267 | 3.538 | 3.327 | 3.014 | 3.278 | 3.019 | 1.351 |
| Inversiones de capital (capex) | -2.171 | -2.207 | -2.202 | -1.777 | -1.885 | -2.177 | -1.638 | -1.394 | -1.135 | -1.121 |
| Flujo de caja de inversión | -2.422 | -2.338 | -3.133 | -1.740 | -2.008 | -2.215 | -1.815 | -1.356 | -9.618 | -248 |
| Flujo de caja de financiación | -6.309 | -5.404 | -7.091 | -7.636 | -5.494 | -2.779 | -4.289 | -10.391 | -5.281 | 11.147 |
| Dividendos pagados | -4.116 | -3.836 | -3.556 | -3.309 | -3.202 | -2.560 | -2.270 | -1.974 | -1.849 | -1.539 |
| Recompra de acciones | -893 | -1.295 | -1.227 | -3.795 | -2.299 | -403 | -718 | -238 | -117 | -522 |
| Emisión de deuda | 5,0 | 223 | 23,0 | 54,0 | 4,0 | 1.283 | 1.842 | 4.009 | 6.742 | 14.934 |
| Amortización de deuda | -1.619 | -760 | -2.498 | -753 | -252 | -1.333 | -3.441 | -12.459 | -9.684 | -1.779 |
| Efecto del tipo de cambio | 71,0 | -96,0 | -23,0 | -122 | -70,0 | 71,0 | -16,0 | -116 | 116 | -483 |
| Variación neta de efectivo | 906 | 720 | -2.986 | 83,0 | 2.961 | 2.978 | 16,0 | -5.563 | -9.213 | 13.619 |
| Flujo de caja libre | 7.395 | 6.351 | 5.059 | 7.804 | 8.648 | — | — | — | — | — |
| Flujo de caja libre apalancado | 6.289 | 5.610 | 4.990 | 7.340 | 7.675 | 5.269 | 3.843 | 4.842 | 3.893 | 1.755 |